14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
May 30, 2017 $16.10 $16.30 $15.75 $16.05 519 910
May 26, 2017 $17.00 $17.20 $16.00 $16.15 581 673
May 25, 2017 $17.10 $17.15 $16.70 $17.05 740 489
May 24, 2017 $17.35 $17.55 $16.52 $16.90 713 314
May 23, 2017 $17.45 $17.73 $16.83 $17.40 516 486
May 22, 2017 $17.70 $17.85 $17.35 $17.45 430 214
May 19, 2017 $18.40 $18.60 $17.65 $17.65 556 983
May 18, 2017 $18.10 $18.55 $17.60 $18.40 655 503
May 17, 2017 $18.45 $18.45 $17.95 $18.05 831 572
May 16, 2017 $18.35 $18.75 $17.85 $18.70 707 608
May 15, 2017 $18.25 $18.55 $17.60 $17.80 469 154
May 12, 2017 $18.85 $19.05 $18.20 $18.20 832 544
May 11, 2017 $18.40 $19.00 $18.25 $18.90 721 842
May 10, 2017 $17.95 $18.65 $17.62 $18.50 597 730
May 09, 2017 $18.80 $18.82 $17.50 $18.05 1 357 075
May 08, 2017 $20.60 $20.65 $18.65 $18.75 858 692
May 05, 2017 $20.80 $21.00 $19.80 $20.75 1 054 481
May 04, 2017 $21.85 $22.20 $21.45 $21.80 604 029
May 03, 2017 $21.65 $22.02 $21.25 $21.80 464 773
May 02, 2017 $21.70 $22.25 $21.05 $21.70 808 725
May 01, 2017 $20.00 $21.62 $19.90 $21.60 808 783
Apr 28, 2017 $20.25 $21.27 $19.20 $20.05 1 458 717
Apr 27, 2017 $22.20 $22.45 $21.20 $21.35 653 350
Apr 26, 2017 $21.95 $22.50 $21.73 $22.15 574 824
Apr 25, 2017 $21.10 $22.10 $20.90 $21.90 672 826
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT